Biochemical predictors of prematurity

Frontiers of Hormone Research

Volumn 27, Issue , 2001, Pages 258-268

  Lockwood, Charles J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL GLAND; BLEEDING; CHORIOAMNIONITIS; DECIDUA; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INFLAMMATION; PATHOPHYSIOLOGY; PREGNANCY; PREMATURE LABOR; PRENATAL DEVELOPMENT; REVIEW; VASCULARIZATION;

ADRENAL GLANDS; CHORIOAMNIONITIS; DECIDUA; FEMALE; HEMORRHAGE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFLAMMATION; OBSTETRIC LABOR, PREMATURE; PREGNANCY;

EID: 0035235746     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000061031     Document Type: Article

References (77)

1. Berkowitz GS, Papiernik E: Epidemiology of preterm birth. Epidemiol Rev 1993;15:414-443.
2. Savitz DA, Blackmore CA, Thorp JM: Epidemiologic characteristics of preterm delivery: Etiologic heterogeneity. Am J Obstet Gynecol 1991;164:467-471.
3. Main DM, Gabbe SG, Richardson D, Strong S: Can preterm deliveries be prevented? Am J Obstet Gynecol 1985;151:892-898.
4. Newman RB, Gill PJ, Wittreich P, Katz M: Maternal perception of prelabor uterine activity. Obstet Gynecol 1986;68:765-769.
5. Copper RL, Goldenberg RL, Davis RO, Cutter GR, DuBard MB, Corliss DK, Andrews JB: Warning symptoms, uterine contractions, and cervical examination findings in women at risk of preterm delivery. Am J Obstet Gynecol 1990;162:748-754.
6. Mercer BM, Goldenberg RL, Das A, Moawad AH, Iams JD, Meis PJ, Copper RL, Johnson F, Horn E, McNellis D, Miodovnik M, Menard MK, Caritis SN, Thurnau GR, Bottoms SF, Roberts J: The preterm prediction study: A clinical risk assessment system. Am J Obstet Gynecol 1996;174:1885-1893.
7. Owen J, Goldenberg RL, Davis RO, Kirk KA, Copper RL: Evaluation of a risk scoring system as a predictor of preterm birth in an indigent population. Am J Obstet Gynecol 1990;163:873-879.
8. Grimes DA, Schulz KF: Randomized controlled trials of home uterine activity monitoring: a review and critique. Obstet Gynecol 1992;79:137-142.
9. Dyson DC, Danbe KH, Bamber JA, Crites YM, Field DR, Maier JA, Newman LA, Ray DA, Walton DL, Armstrong MA: Monitoring women at risk for preterm labor. N Engl J Med 1998;338:15-19.
10. Lockwood CJ, Kuczynski E: Markers of risk for preterm delivery. J Perinat Med 1999;27:5-20.
11. Vale W, Spiess J, Rivier C, Rivier J: Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and B-endorphin. Science 1981;213:1394-1397.
12. Zoumakis E, Makrigiannakis A, Margioris A, Stournaras C, Gravanis A: Corticotropin releasing hormone (CRH) in normal and pregnant uterus: Physiologic implications. Front Biosci 1996;1: e1-8.
13. Petraglia F, Sawchenko PE, Rivier J, Vale W: Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta. Nature 1987;328:717-719.
14. Saijonmaa O, Laatikainen T, Wahlstrom T: Corticotrophin-releasing factor in human placenta: Localization, concentration and release in vitro. Placenta 1988;9:373-385.
15. Jones SA, Brooks AN, Challis JRG: Steroids modulate corticotropin-releasing hormone production in human fetal membranes and placenta. J Clin Endocrinol Metab 1989;68:825-830.
16. Wolfe CDA, Patel SP, Linton EA, Campbell EA, Anderson J, Dornhorst A, Lowry PJ, Jones MT: Plasma CRH in abnormal pregnancy. Br J Obstet Gynaecol 1988;95:1003-1006.
17. Warren WB, Patrick SL, Goland RS: Elevated maternal plasma corticotropin releasing hormone levels in pregnancies complicated by preterm labor. Am J Obstet Gynecol 1992;166:1198-1207.
18. McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R: A placental clock controlling the length of human pregnancy. Nature Med 1995;1:460-463.
19. Lockwood CJ, Radunovic N, Nastic D, Petkovic S, Aigner S, Berkowitz GS: Corticotropin-releasing hormone and related pituitary-adrenal axis hormones in fetal and maternal blood during the second half of pregnancy. J Perinat Med 1996;24:243-251.
20. Hobel CJ, Dunkel-Schetter C, Roesch SC, Castro LC, Arora CP: Maternal plasma corticotropin-releasing hormone associated with stress at 20 weeks' gestation in pregnancies ending in preterm delivery. Am J Obstet Gynecol 1999;180:8257-8263.
21. Wadhwa PD, Porto M, Garite TJ, Chicz-DeMet A, Sandman CA: Maternal corticotropin-releasing hormone levels in the early third trimester predict length of gestation in human pregnancy. Am J Obstet Gynecol 1998;179:1079-1085.
22. Leung TN, Chung TK, Madsen G, McLean M, Chang AM, Smith R: Elevated mid-trimester maternal corticotrophin-releasing hormone levels in pregnancies that delivered before 34 weeks. Br J Obstet Gynaecol 1999;106:1041-1046.
23. Korebrits C, Ramirez MM, Watson L, Brinkman E, Bocking AD, Challis JR: Maternal corticotropin-releasing hormone is increased with impending preterm birth. J Clin Endocrinol Metab 1998;83:1585-1591.
24. Weiner CP, Grant SS, Williamson RA: Relationship between second trimester maternal serum alpha-fetoprotein and umbilical artery Doppler velocimetry and their association with preterm delivery. Am J Perinatol 1991;8:263-268.
25. Gonen R, Perez R, David M, Dar H, Merksamer R, Sharf M: The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications. Obstet Gynecol 1992;80:83-86.
26. Smith R, Mesiano S, Chan EC, Brown S, Jaffe RB: Corticotropin-releasing hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion by human fetal adrenal cortical cells. J Clin Endocrinol Metab 1998;83:2916-2920.
27. Siiteri PK, MacDonald PC: Placental estrogen biosynthesis during human pregnancy. J Clin Endocrinol Metab 1966;26:751-761.
28. Lye SJ, Nicholson BJ, Mascarenhas M, MacKenzie L, Petrocelli T: Increased expression of connexin-43 in the rat myometrium during labor is associated with an increase in the plasma estrogen:progesterone ratio. Endocrinology 1993;132:2380-2386.
29. Bale TL, Dorsa DM: Cloning, novel promoter sequence, and estrogen regulation of a rat oxytocin receptor gene. Endocrinology 1997;138:1151-1158.
30. Windmoller R, Lye SJ, Challis JR: Estradiol modulation of ovine uterine activity. Can J Physiol Pharmacol 1983;61:722-728.
31. Matsui K, Higashi K, Fukunaga K, Miyazaki K, Maeyama M, Miyamoto E: Hormone treatments and pregnancy alter myosin light chain kinase and calmodulin levels in rabbit myometrium. J Endocrinol 1983;97:11-19.
32. Germain AM, Kato L, Villarroel LA, Valenzuela GJ, Séron-Ferré M: Human term and preterm delivery is preceded by a rise in maternal plasma 17β-estradiol. Prenat Neonat Med 1996;1:57-63.
33. Mazor M, Hershkovitz R, Chaim W, Levy J, Sharony Y, Leiberman JR, Glezerman M: Human preterm birth is associated with systemic and local changes in progesterone/17β-estradiol ratios. Am J Obstet Gynecol 1994;171:231-236.
34. Mecenas CA, Giussani DA, Owinby JR, Jenkins SL, Wu XX, Honnebier BOM, Lockwood CJ, Kong L, Guller S, Nathanielsz PW: Production of premature delivery in pregnant rhesus monkeys by androstenedione infusion. Nature Med 1996;2:443-448.
35. McGregor JA, Jackson CM, Lachelin GC, Goodwin TM, Artal R, Hastings C, Dullien V: Salivary estriol as risk assessment for preterm labor: A prospective trial. Am J Obstet Gynecol 1995;173:1337-1342.
36. Gibbs RS, Romero R, Hillier SL, Eschenbach DA, Sweet RL: A review of premature birth and subclinical infection. Am J Obstet Gynecol 1992;166:1515-1528.
37. Meis PJ, Goldenberg RL, Mercer B, Moawad A, Das A, McNellis D, Johnson F, Iams JD, Thom E, Andrews WW: The preterm prediction study: Significance of vaginal infections. National Institute of Child Health and Human Development Department Maternal Fetal Medicine Units. Am J Obstet Gynecol 1995;173:1231-1235.
38. Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, Cotch MF, Edelman R, Pastorek JG 2nd, Rao AV, et al: Association between bacterial vaginosis and preterm delivery of a low birth weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med 1995;333:1737-1742.
39. Dudley DJ, Trautman MS, Araneo BA, Edwin SS, Mitchell MD: Decidual cell biosynthesis of interleukin-6: Regulation by inflammatory cytokines. J Clin Endocrinol Metab 1992;74:884-889.
40. Fortunato SJ, Menon RP, Swan KF, Menon R: Inflammatory cytokine (interleukins 1, 6 and 8 and tumor necrosis factor-alpha) release from cultured human fetal membranes in response to endotoxic lipopolysaccharide mirrors amniotic fluid concentrations. Am J Obstet Gynecol 1996;174:1855-1862.
41. Wenstrom KD, Andrews WW, Tamura T, DuBard MB, Johnston KE, Hemstreet GP: Elevated amniotic fluid interleukin-6 levels at genetic amniocentesis predict subsequent pregnancy loss. Am J Obstet Gynecol 1996;175:830-833.
42. Romero R, Avila C, Santhanam U, Sehgal PB: Amniotic fluid interleukin 6 in preterm labor: Association with infection. J Clin Invest 1990;85:1392-1400.
43. Saito S, Kasahara T, Kato Y, Ishihara Y, Ichijo M: Elevation of amniotic fluid Interleukin 6 (IL-6), IL-8 and granulocyte colony stimulating factor (G-CSF) in term and preterm parturition. Cytokine 1993;5:81-88.
44. Matsuzaki N, Taniguchi T, Shimoya K, Neki R, Okada T, Saji F, Nakayama M, Suehara N, Tanizawa O: Placental interleukin-6 production is enhanced in intrauterine infection but not in labor. Am J Obstet Gynecol 1993;168:94-97.
45. Yoon BH, Jun JK, Romero R, Park KH, Gomez R, Choi JH, Kim IO: Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997;177:19-26.
46. Mitchell MD, Dudley DJ, Edwin SS, Lundin Schiller S: Interleukin-6 stimulates prostaglandin production by human amnion and decidual cells. Eur J Pharmacol 1991;192:189-191.
47. Mitchell MD, Lundin-Schiller S, Edwin SS: Endothelin production by amnion and its regulation by cytokines. Am J Obstet Gynecol 1991;165:120-124.
48. Lockwood CJ, Ghidini A, Wein R, Lapinski R, Casal D, Berkowitz RL: Increased interleukin-6 concentrations in cervical secretions are associated with preterm delivery. Am J Obstet Gynecol 1994;171:1097-1102.
49. Beazley D, Mercer B, McKinney E, Grouse D, Sibai BM: Cervico-vaginal IL-6 and latency in gravidas with preterm labor and PPROM (abstract). Am J Obstet Gynecol 1998;178:8200.
50. Murtha AP, Greig PC, Jimmerson CE, Roitman-Johnson B, Allen J, Herbert WN: Maternal serum interleukin-6 concentrations in patients with preterm premature rupture of membranes and evidence of infection. Am J Obstet Gynecol 1996;175:966-969.
51. Rizzo G, Capponi A, Rinaldo D, Tedeschi D, Arduini D, Romanini C: Interleukin-6 concentrations in cervical secretions identify microbial invasion of the amniotic cavity in patients with preterm labor and intact membranes. Am J Obstet Gynecol 1996;175:812-817.
52. Greig PC, Murtha AP, Jimmerson CJ, Herbert WN, Roitman-Johnson B, Allen J: Maternal serum interleukin-6 during pregnancy and during term and preterm labor. Obstet Gynecol 1997;90:465-469.
53. Potter NT, Kosuda L, Bigazzi PE, Fleming AD, Vintzileos AM, Homon C, Salafia CM: Relationships among cytokines (IL-1, TNF, and IL-8) and histologic markers of acute ascending intrauterine infection. J Matern Fetal Med 1992;1:142-147.
54. Romero R, Mazor M, Avila C, Ceska M, Lindley I: Neutrophil activating peptide-1/interleukin-8 and intra-amniotic infection. Am J Obstet Gynecol 1991;165:813-820.
55. Kanayama N, Terao T: Granulocyte elastase in cervical secretions is a sensitive marker for preterm delivery. J Perinat Med 1991;19:141.
56. Kanayama N, Terao T: The relationship between granulocyte elastase-like activity of cervical mucus and cervical maturation. Acta Obstet Gynecol Scand 1991;70:29-34.
57. Osmers RG, Blaser J, Kuhn W, Tschesche H: Interleukin-8 synthesis and the onset of labor. Obstet Gynecol 1995;86:223-229.
58. Williams MA, Mittendorf R, Lieberman E, Monson RR: Adverse infant outcomes associated with first-trimester vaginal bleeding. Obstet Gynecol 1991;78:14-18.
59. Harger JH, Hsing AW, Tuomala RE, Gibbs RS, Mead PB, Eschenbach DA, Knox GE, Polk BF: Risk factors for preterm rupture of fetal membranes: A multicenter case-control study. Am J Obstet Gynecol 1990;163:130-137.
60. Ekwo EE, Gosselink CA, Moawad A: Unfavorable outcome in penultimate pregnancy and premature rupture of membranes in successive pregnancy. Obstet Gynecol 1992;80:166-172.
61. Strobino B, Pantel-Silverman J: Gestational vaginal bleeding and pregnancy outcome. Am J Epidemiol 1989;129:806-815.
62. Lockwood CJ, Krikun G, Aigner S, Schatz F: Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential. J Clin Endocrinol Metab 1996;81:107-112.
63. Lam H, Hamar B, Rosen T, Schatz F, Lockwood CJ: Thrombin effects on endometrial stromal cell levels of matrix metalloproteinase-1 and metalloproteinase-3 may provide a link between bleeding and rupture of the membranes. Am J Obstet Gynecol 1999;180:83.
64. Elovitz M, Saunders T, Phillippe M: Thrombin, a non-classic uterotonic agonist that produces phasic myometrial contractions. Am J Obstet Gynecol 1999;180:S15.
65. Lockwood CJ, Senyei AE, Dische MR, Casal D, Shah KD, Thung SN, Jones L, Deligdisch L, Garite TJ: Fetal fibronectin in cervical and vaginal secretions defines a patient population at high risk for preterm delivery. N Engl J Med 1991;325:669-674.
66. Morrison JC, Albert JR, McLaughlin BN, Whitworth NS, Roberts WE, Martin RW: Oncofetal fibronectin in patients with false labor as a predictor of preterm delivery. Am J Obstet Gynecol 1993;168:538-542.
67. Bittar RE, Yamasaki AA, Sasaki S, Zugaib M: Cervical fetal fibronectin in patients at increased risk for preterm delivery. Am J Obstet Gynecol 1996;175:178-181.
68. lams JD, Casal D, McGregor JA, Goodwin TM, Seshadri-Kreaden U, Lowensohn R, Lockitch G: Fetal fibronectin improves the accuracy of diagnosis of preterm labor. Am J Obstet Gynecol 1995;173:141-145.
69. Peaceman AM, Andrews WW, Thorp JM, Cliver SP, Lukes A, Iams JD, Coultrip L, Eriksen N, Holbrook RH, Elliott J, Ingardia C, Pietrantoni M: Fetal fibronectin as a predictor of preterm birth in patients with symptoms: A multicenter trial. Am J Obstet Gynecol 1997;177:13-18.
70. Rozenberg P, Goffinet F, Malagrida L, Giudicelli Y, Perdu M, Houssin I, Safe-Femme, Nisand I: Evaluating the risk of preterm delivery: A comparison of fetal fibronectin and transvaginal ultrasonographic measurement of cervical length. Am J Obstet Gynecol 1997;176:196-199.
71. Bartnicki J, Casal D, Seshadri-Kreaden U, Saling E, Vetter K: Fetal fibronectin in vaginal specimens predicts preterm delivery and very-low-birth-weight infants. Am J Obstet Gynecol 1996;174:971-974.
72. Parker J, Bell R, Brennnecke S: Fetal fibronectin in the cervicovaginal fluid of women with threatened preterm labour as a predictor of delivery before 34 weeks' gestation. Aust NZ J Obstet Gynaecol 1995;35:257-261.
73. Lockwood CJ, Wein R, Lapinski R, Casal D, Berkowitz G, Alvarez M, Berkowitz RL: The presence of cervical and vaginal fetal fibronectin predicts preterm delivery in an inner city obstetric population. Am J Obstet Gynecol 1993;169:798-804.
74. Nageotte MP, Casal D, Senyei AE: Fetal fibronectin in patients at increased risk for premature birth. Am J Obstet Gynecol 1994;170:20-25.
75. Hellemans P, Gerris J, Verdonk P: Fetal fibronectin detection for prediction of preterm birth in low risk women. Br J Obstet Gynaecol 1995;102:207-212.
76. Greenhagen JB, Van Wagoner J, Dudley D, Hunter C, Mitchell M, Logsdon V, Casal D, Varner M: Value of fetal fibronectin as a predictor of preterm delivery for a low-risk population. Am J Obstet Gynecol 1996;175:1054-1056.
77. Goldenberg RL, Mercer BM, Meis PJ, Copper RL, Das A, McNellis D: The preterm prediction study: Fetal fibronectin testing and spontaneous preterm birth. Obstet Gynecol 1996;87:643-648.